Activating a brain protein restores waste drainage and slows neurodegeneration

Researchers have identified a molecular leverage point to restore one of the brain's most critical clearance systems: cerebrospinal fluid drainage through the glymphatic network, responsible for eliminating metabolic waste that accumulates during aging. In PS19 transgenic mice with advanced tau pathology, the compound TGN-073 activated aquaporin-4 (AQP4), a water-channel protein in cell membranes, significantly improving cerebrospinal fluid influx measured by advanced MRI. Chronic treatment reduced tau accumulation, neuronal loss, and neuroinflammation (gliosis), while increasing cerebrospinal fluid tau levels, indicating enhanced clearance. Critically, these benefits disappeared in AQP4-deficient mice, demonstrating the mechanism is specific to this protein rather than a off-target effect. For the longevity biohacker and clinician, this finding opens a concrete pharmacological pathway to address glymphatic drainage failure—one of the most mechanistically compelling factors in brain aging and tauopathies—translating into small-molecule drugs an intervention previously confined to genetic manipulation.